Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence
Abstract Since the 2019 novel coronavirus disease (COVID-19) outbreak in 2019 and the pandemic continues for more than one year, a vast amount of drug research has been conducted and few of them got FDA approval. Our objective is to prioritize repurposable drugs using a pipeline that systematically...
Guardado en:
Autores principales: | Kanglin Hsieh, Yinyin Wang, Luyao Chen, Zhongming Zhao, Sean Savitz, Xiaoqian Jiang, Jing Tang, Yejin Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/62b2501ae06e46a290cae495d7afa94f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization
por: Bruce Schultz, et al.
Publicado: (2021) -
Drug Therapeutic-Use Class Prediction and Repurposing Using Graph Convolutional Networks
por: Mapopa Chipofya, et al.
Publicado: (2021) -
Drug repurposing for tooth regeneration: The promising premises
por: T C Divya, et al.
Publicado: (2021) -
A Database of Drug Repurposing Clinical Trials in Oncology
por: Pan Pantziarka, et al.
Publicado: (2021) -
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Steve Rodriguez, et al.
Publicado: (2021)